Adenoviral.βARKct Cardiac Gene Therapy Ameliorates Cardiac Function Following Cardiopulmonary Bypass in A Swine Model. Issue 4 (October 2020)
- Record Type:
- Journal Article
- Title:
- Adenoviral.βARKct Cardiac Gene Therapy Ameliorates Cardiac Function Following Cardiopulmonary Bypass in A Swine Model. Issue 4 (October 2020)
- Main Title:
- Adenoviral.βARKct Cardiac Gene Therapy Ameliorates Cardiac Function Following Cardiopulmonary Bypass in A Swine Model
- Authors:
- Cong, Mulin
Fan, Yiou
Zhu, Fangfang
Ji, Xianfei
Sun, Liangong
Yang, Ming
Li, Na
Li, Qiao
Tan, Qi - Abstract:
- ABSTRACT: Objective: This study is to evaluate the effects of the Adenoviral βARKct (Adv. βARKct) myocardial gene transfection following cardioplegic arrest on cardiopulmonary bypass (CPB) in a swine model. Methods: Swine models of cardioplegic arrest on CPB were established after 5 days of myocardial injection of Adv. βARKct or Adv. luciferase. The pigs were randomized into Adv. βARKct, Control, and Sham groups. Invasive hemodynamics, cardiac function, biomarkers, and tissue morphology were assessed. Results: Baseline data were similar among these groups. Hemodynamics and cardiac function showed a deteriorating trend throughout 6 h after weaning in βARKct and Control groups. Compared with Control group, Adv. βARKct treatment significantly elevated global and regional ventricular function (cardiac output, dp/dtmax, Ejection fraction, peak systolic longitudinal strain, and peak systolic strain rate) and altered hemodynamics (cardiac cycle efficiency and systemic vascular resistance). Moreover, inotropic score in βARKct group was gradually decreased to 5.0 ± 1.1, compared with Control group (6.2 ± 0.9), at 6 h after weaning. Biomarkers in βARKct group were significantly better than in Control group. Meanwhile, βARKct treatment reduced the histopathologic injuries, rescued β1-AR, SERCA2a, and RyR2 levels, and decreased the GRK2 levels in myocardial cells. Conclusion: Adv.βARKct inhibits GRK2 and ameliorates myocardial injuries following cardioplegic arrest on CPB, viaABSTRACT: Objective: This study is to evaluate the effects of the Adenoviral βARKct (Adv. βARKct) myocardial gene transfection following cardioplegic arrest on cardiopulmonary bypass (CPB) in a swine model. Methods: Swine models of cardioplegic arrest on CPB were established after 5 days of myocardial injection of Adv. βARKct or Adv. luciferase. The pigs were randomized into Adv. βARKct, Control, and Sham groups. Invasive hemodynamics, cardiac function, biomarkers, and tissue morphology were assessed. Results: Baseline data were similar among these groups. Hemodynamics and cardiac function showed a deteriorating trend throughout 6 h after weaning in βARKct and Control groups. Compared with Control group, Adv. βARKct treatment significantly elevated global and regional ventricular function (cardiac output, dp/dtmax, Ejection fraction, peak systolic longitudinal strain, and peak systolic strain rate) and altered hemodynamics (cardiac cycle efficiency and systemic vascular resistance). Moreover, inotropic score in βARKct group was gradually decreased to 5.0 ± 1.1, compared with Control group (6.2 ± 0.9), at 6 h after weaning. Biomarkers in βARKct group were significantly better than in Control group. Meanwhile, βARKct treatment reduced the histopathologic injuries, rescued β1-AR, SERCA2a, and RyR2 levels, and decreased the GRK2 levels in myocardial cells. Conclusion: Adv.βARKct inhibits GRK2 and ameliorates myocardial injuries following cardioplegic arrest on CPB, via stabilizing β1-AR, reducing mitochondrial damages and restoring sarcoplasmic reticulum Ca 2+ -handling protein expression. Abstract : Supplemental Digital Content is available in the text … (more)
- Is Part Of:
- Shock. Volume 54:Issue 4(2020)
- Journal:
- Shock
- Issue:
- Volume 54:Issue 4(2020)
- Issue Display:
- Volume 54, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 54
- Issue:
- 4
- Issue Sort Value:
- 2020-0054-0004-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-10
- Subjects:
- βARKct -- cardiopulmonary bypass (CPB) -- gene therapy -- myocardial injuries
Shock -- Periodicals
Shock -- Periodicals
Choc (Pathologie) -- Périodiques
Shock
Periodicals
616.0475 - Journal URLs:
- http://www.shockjournal.com ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00024382-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/SHK.0000000000001499 ↗
- Languages:
- English
- ISSNs:
- 1073-2322
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8267.443000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20522.xml